amiodarone has been researched along with Severe Acute Respiratory Syndrome in 2 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Severe Acute Respiratory Syndrome: A viral disorder characterized by high FEVER, dry COUGH, shortness of breath (DYSPNEA) or breathing difficulties, and atypical PNEUMONIA. A virus in the genus CORONAVIRUS is the suspected agent.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Navarese, EP | 1 |
Musci, RL | 1 |
Frediani, L | 1 |
Gurbel, PA | 1 |
Kubica, J | 1 |
Stadler, K | 1 |
Ha, HR | 1 |
Ciminale, V | 1 |
Spirli, C | 1 |
Saletti, G | 1 |
Schiavon, M | 1 |
Bruttomesso, D | 1 |
Bigler, L | 1 |
Follath, F | 1 |
Pettenazzo, A | 1 |
Baritussio, A | 1 |
1 review available for amiodarone and Severe Acute Respiratory Syndrome
Article | Year |
---|---|
Ion channel inhibition against COVID-19: A novel target for clinical investigation.
Topics: Amiodarone; Communicable Disease Control; Coronavirus Infections; COVID-19; Female; Humans; Ion Chan | 2020 |
1 other study available for amiodarone and Severe Acute Respiratory Syndrome
Article | Year |
---|---|
Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level.
Topics: Amiodarone; Animals; Antiviral Agents; Cathepsin L; Cathepsins; Cell Membrane; Chlorocebus aethiops; | 2008 |